<VariationArchive RecordType="classified" VariationID="10002" VariationName="NM_000216.4(ANOS1):c.1842+412_*1083del" VariationType="Deletion" Accession="VCV000010002" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-24" DateCreated="2020-01-16" MostRecentSubmission="2020-01-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25041" VariationID="10002">
      <GeneList>
        <Gene Symbol="ANOS1" FullName="anosmin 1" GeneID="3730" HGNC_ID="HGNC:6211" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="8528874" stop="8732137" display_start="8528874" display_stop="8732137" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="8496914" stop="8700226" display_start="8496914" display_stop="8700226" Strand="-" />
          </Location>
          <OMIM>300836</OMIM>
          <Haploinsufficiency last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANOS1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANOS1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000216.4(ANOS1):c.1842+412_*1083del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="8531912" stop="8535179" display_start="8531912" display_stop="8535179" variantLength="3268" positionVCF="8531911" referenceAlleleVCF="CTAATTTGTAGCATAAAACATTTCCAAAAAGTAAGATATACTAGATTTGAAAGCATATGGGTGAATTAAATGCAAATAACTGTCCTTCTCTATCAATCAAAGGAATTTTTAAAACATTACCAATAATATTCTAGCACACAAAGACCTTTCTTTGATTAAGAAAAGGCAAATCTCTGCAAAGATTTAAACATGCTCAATAGTTGGGATTTTTTCATTTGAAGCAAGAAGTTTTGTGAATTTTCAGATGGTGAAACAAAAGTGCACCAAAAGCTATTATCTGCATTGAGGAAAATAAGGGAAAATATAAATAAGATAACATATCAGGAAAATCTCTCACATAATAGGATCAAATATTAAAAGGCATCCCCAAGAAATAATTTTCATTTCTCCAAGGTAAAATCTGATTAGCAGCTTATTTCATTGAGTTCCTCTGGCTTGGGTGTCTTTTGTAAATCATAATTTATAGAGGGAACTTTGATTTACCTTTGCATAAAGAGCAGCACAAGGTACTTAAAGTAGGAGCATTTTTAGATTTAAATTCGCTGGTATATTTTAGATTACACATTTTCATTTAAAAATCACCTAGGATAAAAATGATCTTAGGAAAGATTCAAAAAAACAAAGCTGTGTAATCTTAGTTGATTTTTCATATCGAATCAATAATTTAGTCAAAAATATATTTTATTGATTAGATTTACGCTTAGTGTTATGTGTGAATTGTGTATTTGTTACTCTCCTTTTTGGGGCGGAGTTTGGTGCTCCAAATTCAGGGAAAACTGAGTTCTGTTGTAATTCAATAGAAATGAGCGACACCATACATGAAAACAAAATTTAGCATTAAACAGGCCTATTCTTCATTTTCTCCATGCTTGTAGGGAACTGGTGTCTGTCTTCACCAATCTACTGTTTCTCACTTGTCTCCAGATGCGTCCATGATTGACAGAAGTTCTTCCTGCACTAAAGTCACATAGGAGAGTCCGGGCCTCTGAGCAGTTCCCACTGCCTCTGGAAGTGTGCATGTCTCGTGGCCGAAGTTCAACAAGCTTACACATCTGTGCAATTTCACAAAATCTTTTTGAACAGTTTAGTATCTTTCTGGAGAAGGCTTGTAATGATGTGGATGACGATGCTTAAGATGAGATCCTAAAAAGTGACAAAATATGTCAGTCACATCCATTTGTATGTATCAAATAAATGATAGAATTACCTTTATTTGTAGAAAAAGCACGAGACCCTGGCAAATGTTCCTTCCTATGACCATGTCTTTCCTATTCTGAATCTGAATGTACAACCACACTCTTTCTCTCCTTTTCCTGTTTTTCTCTTCCTCTTTGATGTCTTCCCAAACTATAAAATAACAAGAAAAAGAAGACAAGCTCCTTTCCTTAAGCTCACACTTATCCAATCAAACCATAATCCTTTTTTATTTGCTCAAAGAAGTTTAAAAATTATCAAATACTTCTGTTAAAAGGAATTTCTATGAAGGAATATCAGAAAAGCATTTATCTGACAAAAATTTTAGAGGCTATCAAGCTCTCCCATTGTGATAGTTTTTGTTTTTCTTCAAATTATAAGCATACCAAGTTATCAATTATAAGCATACCAATCTATCATTTAAAAAAATCAGAGTTAAAACTATGACTAATTCTCAATGTTTTGTCCACACACTAGTCATCAGACACTTTTTTAAAAAATTTAAGCTAGAAAATAAAGTAAACGAAGTACATAATTTAAAAATCAGCAAGAGGCTGTTTTGAAAATCTAGGTGACAATTTTCTTTTTAAATTTTACTTGATTTAGCAATAAATGAAGTAGGTGGACTTGGGTCATATCATGAAGAAAATTCATAATATTTATTACAGTAATATCTATGTAACAAGAACATAAGTTCCTTAGCAAAATATTATTTCCTATATTGTGATATATGAAAATCTTGATTTAAAAATATTTCAGATATGAGACTACAGATTTTTTTCCCATATGTATTTATGGTTTAAAAGACAAGGAAAAAAGCATGCATTACATAGGGGAAAATGCAAGGAAGGAAAAAAAAAACAAAGGAAGGATAGAGGAAAGGAGAAAAGAAGAGAGGGAAGAATGAAGGAGGGAGGGAGAGAGGATGGAGAAAGGAAACAAGGAAGGAGCAAAGAAAGGGAGAAAAGCGGGGAAGAGGGAGGGAGGGAGAAAAAGAACAATTAAGCATCAACTATGCAATGTATACTACAGGTGCCTGGAATAGAATCTAGTAAGTCGGTACAAACAGGGAGAAAGAATTTCAGATGATGACAATTTCCCTATCTCATAGAAACCTGTACTAGTGTATTTATTTGTTTTCATTTTCCAGCAAGATTTTTCTCTATGTCCACAAGACCTGACAGGATGGCTTAATGCCCTGGCACCCCACTCACTGTGTGCTGAAGAGGGTGGGAGCTCCGGCGTCCGGAACGTCTTGATGGTGGCCGGCCCCTCCCCTCCTGGGGTCAGCACTTGCACTTCCAGTCGGTAAAGAGTAGATGGTCTCAGATTGGGCACTGTTAGGACATAATGATCCTAAGGGGACAACATAAAAGAGCATGCTCACCGACAACCTTTCAGAGACAACATGCAATGCACAGAGAGCCTAGAACAGTTTTTCCCCCACTGGAGAATATCATACACAGGCAAGTTTGGTTGCTTTGTAAAGGCATAGTTTAATTTATAGACTATTTCTCATTTGTGGGGGTTCTCTGCCATATGGTTTCTTAGCACCTCACTCAATTCTTGGCAGCCTAAGACACTTGGCAGAGTTAAAATATGCTGAGGTGCCAGTTCTCAGGGCTCACTCCTGGGATTTTATTTATTTTTTTAATTCCTTAACGTAAAACTTTCCCATGGTTTAAAGTCTTCAGCTGCACATCTTGTGATGTGAACTCTTGATAGTCCAAATTTCAGTGAATGAGCCAACTGTTTTTCTTAAAACACAGTATCTGTCAATGCCCATAACTGAAAATGTTTATTTTTATGCCAACATATTCTTCTCAAAACTCAATAAAACCTAGTACATTTATAGAATAACTACTCTCTAATTCCATGGAATTTTTCCTTCTGAGATTTAAGTTGTGTTTCTTTCCCTCTCTGCCCCTCTTTTTGGATTTTGTAACGGTAGTTGGCTATTCTAAGGGCATTTTCAGAGAGGGTAAAATCCCACACATGATTTTTTTTTTTTTTTTTTGAAGCCAAGGAATTAAGTGGCCTGGAAGACAGGCCAACTCATTACAGCCTCGAGCCAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="8499953" stop="8503220" display_start="8499953" display_stop="8503220" variantLength="3268" positionVCF="8499952" referenceAlleleVCF="CTAATTTGTAGCATAAAACATTTCCAAAAAGTAAGATATACTAGATTTGAAAGCATATGGGTGAATTAAATGCAAATAACTGTCCTTCTCTATCAATCAAAGGAATTTTTAAAACATTACCAATAATATTCTAGCACACAAAGACCTTTCTTTGATTAAGAAAAGGCAAATCTCTGCAAAGATTTAAACATGCTCAATAGTTGGGATTTTTTCATTTGAAGCAAGAAGTTTTGTGAATTTTCAGATGGTGAAACAAAAGTGCACCAAAAGCTATTATCTGCATTGAGGAAAATAAGGGAAAATATAAATAAGATAACATATCAGGAAAATCTCTCACATAATAGGATCAAATATTAAAAGGCATCCCCAAGAAATAATTTTCATTTCTCCAAGGTAAAATCTGATTAGCAGCTTATTTCATTGAGTTCCTCTGGCTTGGGTGTCTTTTGTAAATCATAATTTATAGAGGGAACTTTGATTTACCTTTGCATAAAGAGCAGCACAAGGTACTTAAAGTAGGAGCATTTTTAGATTTAAATTCGCTGGTATATTTTAGATTACACATTTTCATTTAAAAATCACCTAGGATAAAAATGATCTTAGGAAAGATTCAAAAAAACAAAGCTGTGTAATCTTAGTTGATTTTTCATATCGAATCAATAATTTAGTCAAAAATATATTTTATTGATTAGATTTACGCTTAGTGTTATGTGTGAATTGTGTATTTGTTACTCTCCTTTTTGGGGCGGAGTTTGGTGCTCCAAATTCAGGGAAAACTGAGTTCTGTTGTAATTCAATAGAAATGAGCGACACCATACATGAAAACAAAATTTAGCATTAAACAGGCCTATTCTTCATTTTCTCCATGCTTGTAGGGAACTGGTGTCTGTCTTCACCAATCTACTGTTTCTCACTTGTCTCCAGATGCGTCCATGATTGACAGAAGTTCTTCCTGCACTAAAGTCACATAGGAGAGTCCGGGCCTCTGAGCAGTTCCCACTGCCTCTGGAAGTGTGCATGTCTCGTGGCCGAAGTTCAACAAGCTTACACATCTGTGCAATTTCACAAAATCTTTTTGAACAGTTTAGTATCTTTCTGGAGAAGGCTTGTAATGATGTGGATGACGATGCTTAAGATGAGATCCTAAAAAGTGACAAAATATGTCAGTCACATCCATTTGTATGTATCAAATAAATGATAGAATTACCTTTATTTGTAGAAAAAGCACGAGACCCTGGCAAATGTTCCTTCCTATGACCATGTCTTTCCTATTCTGAATCTGAATGTACAACCACACTCTTTCTCTCCTTTTCCTGTTTTTCTCTTCCTCTTTGATGTCTTCCCAAACTATAAAATAACAAGAAAAAGAAGACAAGCTCCTTTCCTTAAGCTCACACTTATCCAATCAAACCATAATCCTTTTTTATTTGCTCAAAGAAGTTTAAAAATTATCAAATACTTCTGTTAAAAGGAATTTCTATGAAGGAATATCAGAAAAGCATTTATCTGACAAAAATTTTAGAGGCTATCAAGCTCTCCCATTGTGATAGTTTTTGTTTTTCTTCAAATTATAAGCATACCAAGTTATCAATTATAAGCATACCAATCTATCATTTAAAAAAATCAGAGTTAAAACTATGACTAATTCTCAATGTTTTGTCCACACACTAGTCATCAGACACTTTTTTAAAAAATTTAAGCTAGAAAATAAAGTAAACGAAGTACATAATTTAAAAATCAGCAAGAGGCTGTTTTGAAAATCTAGGTGACAATTTTCTTTTTAAATTTTACTTGATTTAGCAATAAATGAAGTAGGTGGACTTGGGTCATATCATGAAGAAAATTCATAATATTTATTACAGTAATATCTATGTAACAAGAACATAAGTTCCTTAGCAAAATATTATTTCCTATATTGTGATATATGAAAATCTTGATTTAAAAATATTTCAGATATGAGACTACAGATTTTTTTCCCATATGTATTTATGGTTTAAAAGACAAGGAAAAAAGCATGCATTACATAGGGGAAAATGCAAGGAAGGAAAAAAAAAACAAAGGAAGGATAGAGGAAAGGAGAAAAGAAGAGAGGGAAGAATGAAGGAGGGAGGGAGAGAGGATGGAGAAAGGAAACAAGGAAGGAGCAAAGAAAGGGAGAAAAGCGGGGAAGAGGGAGGGAGGGAGAAAAAGAACAATTAAGCATCAACTATGCAATGTATACTACAGGTGCCTGGAATAGAATCTAGTAAGTCGGTACAAACAGGGAGAAAGAATTTCAGATGATGACAATTTCCCTATCTCATAGAAACCTGTACTAGTGTATTTATTTGTTTTCATTTTCCAGCAAGATTTTTCTCTATGTCCACAAGACCTGACAGGATGGCTTAATGCCCTGGCACCCCACTCACTGTGTGCTGAAGAGGGTGGGAGCTCCGGCGTCCGGAACGTCTTGATGGTGGCCGGCCCCTCCCCTCCTGGGGTCAGCACTTGCACTTCCAGTCGGTAAAGAGTAGATGGTCTCAGATTGGGCACTGTTAGGACATAATGATCCTAAGGGGACAACATAAAAGAGCATGCTCACCGACAACCTTTCAGAGACAACATGCAATGCACAGAGAGCCTAGAACAGTTTTTCCCCCACTGGAGAATATCATACACAGGCAAGTTTGGTTGCTTTGTAAAGGCATAGTTTAATTTATAGACTATTTCTCATTTGTGGGGGTTCTCTGCCATATGGTTTCTTAGCACCTCACTCAATTCTTGGCAGCCTAAGACACTTGGCAGAGTTAAAATATGCTGAGGTGCCAGTTCTCAGGGCTCACTCCTGGGATTTTATTTATTTTTTTAATTCCTTAACGTAAAACTTTCCCATGGTTTAAAGTCTTCAGCTGCACATCTTGTGATGTGAACTCTTGATAGTCCAAATTTCAGTGAATGAGCCAACTGTTTTTCTTAAAACACAGTATCTGTCAATGCCCATAACTGAAAATGTTTATTTTTATGCCAACATATTCTTCTCAAAACTCAATAAAACCTAGTACATTTATAGAATAACTACTCTCTAATTCCATGGAATTTTTCCTTCTGAGATTTAAGTTGTGTTTCTTTCCCTCTCTGCCCCTCTTTTTGGATTTTGTAACGGTAGTTGGCTATTCTAAGGGCATTTTCAGAGAGGGTAAAATCCCACACATGATTTTTTTTTTTTTTTTTTGAAGCCAAGGAATTAAGTGGCCTGGAAGACAGGCCAACTCATTACAGCCTCGAGCCAA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.8499953_8503220del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.8499953_8503220del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.8531912_8535179del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.8531912_8535179del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007088.2" sequenceAccession="NG_007088" sequenceVersion="2" change="g.202008_205275del">
            <Expression>NG_007088.2:g.202008_205275del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000216.4" sequenceAccession="NM_000216" sequenceVersion="4" change="c.1842+412_*1083del" MANESelect="true">
            <Expression>NM_000216.4:c.1842+412_*1083del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300836.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 300836.0001 from the sequence across the breakpoint provided in Figure 2 of the paper by Bick et al., 1992 (PubMed 1594017).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000216.4(ANOS1):c.1842+412_*1083del AND Hypogonadotropic hypogonadism 1 with or without anosmia" Accession="RCV000010685" Version="7">
        <ClassifiedConditionList TraitSetID="2830">
          <ClassifiedCondition DB="MedGen" ID="C1563719">Hypogonadotropic hypogonadism 1 with or without anosmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-01-16" MostRecentSubmission="2020-01-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1594017</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1639422</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1904396</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2830" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6234" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome, type 1, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM AND ANOSMIA</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA</ElementValue>
                <XRef Type="Allelic variant" ID="300836.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300836.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypogonadotropic hypogonadism 1 with or without anosmia</ElementValue>
                <XRef ID="MONDO:0010635" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kallmann syndrome 1</ElementValue>
                <XRef ID="Kallmann+syndrome%2C+type+1%2C+X-linked/3949" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYSPLASIA OLFACTOGENITALIS OF DE MORSIER</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">KAL1</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HH1</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HHA</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">KMS</ElementValue>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</Attribute>
                <XRef ID="NBK1334" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ANOSMIC HYPOGONADISM</Attribute>
                <XRef Type="MIM" ID="308700" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000508943" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556730" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556729" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558347" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511585" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512869" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529045" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569425" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3071" />
                <XRef ID="3071" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <XRef ID="478" DB="Orphanet" />
              <XRef ID="C1563719" DB="MedGen" />
              <XRef ID="MONDO:0010635" DB="MONDO" />
              <XRef Type="MIM" ID="308700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30911" SubmissionDate="2019-12-23" DateLastUpdated="2020-01-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300836.0001_HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA" title="ANOS1, 3,300-BP DEL_HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA" />
        <ClinVarAccession Accession="SCV000030911" DateUpdated="2020-01-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient and his brother with Kallmann syndrome (HH1; 308700), Bick et al. (1992) detected a 3,300-bp deletion in the KALIG1 (KAL1) gene. Bick et al. (1992) studied 77 families in which one or more men had hypogonadotropic hypogonadism, characterized by hypogonadism and low serum concentrations of testosterone, luteinizing hormone, and follicle-stimulating hormone. None had evidence of deficiency of any other pituitary hormone or of a hypothalamic or pituitary mass lesion. Among the 77 families, the probands had anosmia in 52, hyposmia in 7, and a normal sense of smell in 18. In 10 of the families some affected members were brothers, and in 6 families some belonged to at least 2 generations related through female members, indicating a pattern of X-linked inheritance. In only 1 family was an abnormality on Southern blot analysis discovered. Bick et al. (1992) demonstrated that this patient and his brother had inherited from their mother a 3,300-bp deletion entirely confined within the 210-kb KALIG1 gene. They sequenced the 5-prime and 3-prime boundaries of the deleted region. A 6-bp homology (CAAATT) was found at the deletion breakpoint. It is possible that this short stretch of sequence homology was involved in the molecular mechanism that underlay the event producing the deletion. Similar nonhomologous recombinations as the basis of intragenic deletions have been postulated (Woods-Samuels et al., 1991; Bernatowicz et al., 1992). The deletion included the penultimate exon which encodes one of the domains of the KALIG1 gene that is homologous with molecules involved in neural cell adhesion. In this family, 1 brother was born with microphallus, scrotal hypoplasia, and an undescended testis. His brother had normal genitalia at birth, but by 4 months of age his testes had retracted and his penis appeared involuted, closely resembling his brother's genitalia at the same age. Both had anosmia; their mother had a normal sense of smell.</Attribute>
              <Citation>
                <ID Source="PubMed">1594017</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1904396</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1639422</ID>
              </Citation>
              <XRef DB="OMIM" ID="308700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANOS1" />
          </GeneList>
          <Name>ANOS1, 3,300-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3,300-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300836.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30911" TraitType="Disease" MappingType="Name" MappingValue="HYPOGONADOTROPIC HYPOGONADISM 1 WITH ANOSMIA" MappingRef="Preferred">
        <MedGen CUI="C1563719" Name="Hypogonadotropic hypogonadism 1 with or without anosmia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

